These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4261868)

  • 1. Relative serum antiplasmin levels in normal and hemophilic dogs treated with choline.
    McDonald D; Jackson B; Boudreaux HB; Myers RB
    Thromb Diath Haemorrh; 1972 Apr; 27(2):220-7. PubMed ID: 4261868
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adrenaline infusions on blood coagulation in normal and haemophilia B dogs.
    Ozge AH; Rowsell HC; Downie HG; Mustard JF
    Thromb Diath Haemorrh; 1966 May; 15(3):349-64. PubMed ID: 5989023
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Disappearance of canine small active factor VIII fragment following transfusion in hemophilic dogs.
    Allain JP; Cooper HA; Wagner RH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607-8. PubMed ID: 1198531
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilic dogs response to Bridge anticoagulant neutralizing agent.
    Nour-Eldin F
    Transfusion; 1983; 23(6):533-4. PubMed ID: 6417849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of bovine factor VIII in the hemophilic dog.
    Gentry PA; Kirby EP; Gentry RD
    Thromb Haemost; 1981 Aug; 46(2):485-8. PubMed ID: 6795739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies in measured factor VIII activity in patients treated with factor VIII concentrate of human or porcine origin.
    Teitel JM; Lau HK; Garvey MB
    Thromb Haemost; 2002 Jul; 88(1):159-60. PubMed ID: 12152659
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryoprecipitate and the use of the plastic blood bag system in the management of haemophilia and other coagulation disorders.
    Dormandy KM
    Proc R Soc Med; 1968 Jun; 61(6):595-8. PubMed ID: 5301887
    [No Abstract]   [Full Text] [Related]  

  • 9. Low factor VIII levels are a risk factor for bleeding in patients with factor XI deficiency.
    Weiss HJ
    J Thromb Haemost; 2005 Jan; 3(1):181-2. PubMed ID: 15634287
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital combined deficiency of factor V and factor 8. A case report and the effect of transfusion of normal plasma and hemophilic blood.
    Saito H; Shioya M; Koie K; Kamiya T; Katsumi O
    Thromb Diath Haemorrh; 1969 Nov; 22(2):316-25. PubMed ID: 5380951
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercoagulability in acute glomerulonephritis.
    Ekert H; Powell H; Muntz R
    Lancet; 1972 Apr; 1(7757):965-6. PubMed ID: 4112134
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions.
    Kingdon HS; Hassell TM
    Blood; 1981 Nov; 58(5):868-72. PubMed ID: 6794675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Test reagents for the determination of factor VIII activity in plasma and coagulation-active plasma fractions].
    Stein P; Kirsek WJ
    Dtsch Gesundheitsw; 1972 Oct; 27(43):2056-8. PubMed ID: 5087016
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor VIII (anti-hemophilic A factor). Biology, physiology, pathology and genetics].
    Meyer D; Dray L; Allain JP; Larrieu MJ
    Pathol Biol (Paris); 1972; 20(11):607-23. PubMed ID: 4558579
    [No Abstract]   [Full Text] [Related]  

  • 17. [in vivo reappearance of injected cryoprecopitate (factor VIII concentrates) in patients with hemophilia A].
    Kuble M; Wegner H; Cron D
    Z Gesamte Inn Med; 1973 Oct; 28(20):608-14. PubMed ID: 4767194
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 19. [DDAVP and its effect on factor VIII activity (author's transl)].
    Sikorová J; Vorlová Z
    Cas Lek Cesk; 1981 May; 120(18):553-6. PubMed ID: 6794913
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the spleen on canine factor VIII levels.
    McKee PA; Coussons RT; Buckner RG; Williams GR; Hampton JW
    J Lab Clin Med; 1970 Mar; 75(3):391-402. PubMed ID: 5416900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.